These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5744593)

  • 1. [Pharmacological approach to the mechanism of potentiation of hypnotics by various monoamine oxidase inhibitors].
    Simon P; Tillement JP; Lwoff JM; Boissier JR
    Therapie; 1968; 23(4):849-61. PubMed ID: 5744593
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interference of MAOI and barbiturate hypnotics. Hypothesis on the mechanisms of action].
    Boismare F; Camacho M; Denys A; Lechat P; Levy J; Michel-Ber E
    Therapie; 1968; 23(4):863-77. PubMed ID: 5744594
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental sleep by non-barbiturate hypnotics and modifiers of hepatic microsome activity].
    Boismare F; Camacho M; Lechat P
    Therapie; 1969; 24(6):949-54. PubMed ID: 5367189
    [No Abstract]   [Full Text] [Related]  

  • 4. [Interaction of drug preparations and ethyl alcohol].
    Skakun NP; Oleĭnik AN
    Ter Arkh; 1984; 56(5):130-4. PubMed ID: 6147024
    [No Abstract]   [Full Text] [Related]  

  • 5. Potentiation of the inhibition of rat liver monoamine oxidase-a by clorgyline after pretreatment with SKF 525A.
    Fowler CJ
    Med Biol; 1980 Oct; 58(5):285-7. PubMed ID: 7206835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between drugs.
    Lant AF
    Trans Med Soc Lond; 1974; 90():142-55. PubMed ID: 4469105
    [No Abstract]   [Full Text] [Related]  

  • 7. [Structure-action relations of monoamine oxidase inhibitors].
    Matthies H; Fähse C; Lietz W; Jassmann E
    Acta Biol Med Ger; 1967; 19(3):447-61. PubMed ID: 5591162
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dangers of drug combinations (author's transl)].
    Zbinden G
    Schweiz Rundsch Med Prax; 1976 Mar; 65(11):329-33. PubMed ID: 1257190
    [No Abstract]   [Full Text] [Related]  

  • 9. Alcohol and its drug interactions.
    Seixas FA
    Ann Intern Med; 1975 Jul; 83(1):86-92. PubMed ID: 1147446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of some drugs on toxicity and rate of metabolism of lidocaine and mepivacaine. Experimental study on mice and rats.
    Heinonen J
    Ann Med Exp Biol Fenn; 1966; 44():Suppl 3:1-43. PubMed ID: 4379865
    [No Abstract]   [Full Text] [Related]  

  • 11. Interactions of delta-tetrahydrocannabinol with barbiturates and methamphetamine.
    Kubena RK; Barry H
    J Pharmacol Exp Ther; 1970 May; 173(1):94-100. PubMed ID: 5442307
    [No Abstract]   [Full Text] [Related]  

  • 12. [To the study of the mechanism of potentiation of hypnotic effect of hexenal by 3,5-dimethyl-4-brompyrazol].
    Avakumov VM; Batulin IuM
    Farmakol Toksikol; 1968; 31(4):402-5. PubMed ID: 5698126
    [No Abstract]   [Full Text] [Related]  

  • 13. [Monoamine oxidase inhibitors and cardiac action of G-strophanthin].
    Loubatières A; Bouyard P; Klein M
    C R Seances Soc Biol Fil; 1966; 160(8):1638-42. PubMed ID: 4227883
    [No Abstract]   [Full Text] [Related]  

  • 14. [Relations between inhibition of cerebral monoamine oxidase in mice and the pyridoxal-5-phosphate-monoamine oxidase inhibitor pharmacological antagonism in the presence of 3,4-dihydroxyphenylalanine].
    Lévy J; Michel-Ber E
    J Physiol (Paris); 1965; 57(4):475-83. PubMed ID: 5848057
    [No Abstract]   [Full Text] [Related]  

  • 15. Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile.
    Caille D; Bergis OE; Fankhauser C; Gardes A; Adam R; Charieras T; Grosset A; Rovei V; Jarreau FX
    J Pharmacol Exp Ther; 1996 Apr; 277(1):265-77. PubMed ID: 8613929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of the pharmacological effect of monoamine oxidase inhibitors].
    Gorkin VZ
    Vestn Akad Med Nauk SSSR; 1984; (11):72-5. PubMed ID: 6396999
    [No Abstract]   [Full Text] [Related]  

  • 17. [Interactions between adrenergics, adrenolytics and monoamine oxidase inhibitors].
    Marmo E; Sarluca F
    Clin Ter; 1966 Apr; 37(1):3-24. PubMed ID: 5919308
    [No Abstract]   [Full Text] [Related]  

  • 18. [Neurochemical and behavioral study on the mechanism of the antidepressant and anxiolytic effect of co-administration of lithium and monoamine oxidase inhibitors].
    Kitaichi Y
    Hokkaido Igaku Zasshi; 2004 Jan; 79(1):93-101. PubMed ID: 14978979
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
    Youdim MB; Weinstock M
    Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of intraneuronal monoamine oxidase on the sympathomimetic response to amphetamine.
    Obianwu HO
    Acta Pharmacol Toxicol (Copenh); 1970; 28(1):69. PubMed ID: 5314439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.